feed,title,long_url,short_url
🔐MarketWatch,Madrigal Pharmaceuticals’ stock up 5% as company starts rolling submission for FDA approval of NASH treatment,http://www.marketwatch.com/news/story/madrigal-pharmaceuticals-stock-up-5/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7222%2D0E646E37B962%7D&siteid=rss,https://da.gd/SATwH
